Atlas Trials

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Clinical trial NCT06310915 · UNKNOWN

Trial details

NCT number
NCT06310915
Sponsor
Guangzhou Institute of Respiratory Disease
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer Stage IIIB/IV
Start date
2023-03-17
Primary completion
2025-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.